Last reviewed · How we verify

Three doses of Pentamidine

Fundação de Medicina Tropical Dr. Heitor Vieira Dourado · Phase 2 active Small molecule

Three doses of Pentamidine is a Small molecule drug developed by Fundação de Medicina Tropical Dr. Heitor Vieira Dourado. It is currently in Phase 2 development. Also known as: Pentacarinat® (7mg/kg) in three weekly applications.

At a glance

Generic nameThree doses of Pentamidine
Also known asPentacarinat® (7mg/kg) in three weekly applications
SponsorFundação de Medicina Tropical Dr. Heitor Vieira Dourado
ModalitySmall molecule
PhasePhase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Three doses of Pentamidine

What is Three doses of Pentamidine?

Three doses of Pentamidine is a Small molecule drug developed by Fundação de Medicina Tropical Dr. Heitor Vieira Dourado.

Who makes Three doses of Pentamidine?

Three doses of Pentamidine is developed by Fundação de Medicina Tropical Dr. Heitor Vieira Dourado (see full Fundação de Medicina Tropical Dr. Heitor Vieira Dourado pipeline at /company/funda-o-de-medicina-tropical-dr-heitor-vieira-dourado).

Is Three doses of Pentamidine also known as anything else?

Three doses of Pentamidine is also known as Pentacarinat® (7mg/kg) in three weekly applications.

What development phase is Three doses of Pentamidine in?

Three doses of Pentamidine is in Phase 2.

Related